Treatment Modalities to Improve Response in Tumors Refractory to Standard Immunotherapy Approaches

Time: 12:30 pm
day: Preclinical Track - Day 1 am


  • Low dose radiation in combination with immunotherapy in advanced tumors
  • Mechanistic insights into radioimmunotherapy resistance
  • Reversing immune dysfunction via interference of TGFbeta pathway with inhibitors of the integrin avB8